1 |
Zhou P, Yang X, Wang X, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020, 579: 270-273.
|
2 |
Sharma A, Tiwari S, Deb Manas K, et al. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies[J]. Int J Antimicrob Agents, 2020, 56: 106054.
|
3 |
Yang Y, Xiao Z, Ye K, et al. SARS-CoV-2: characteristics and current advances in research[J]. Virol J, 2020, 17: 117.
|
4 |
World Health Organization. Coronavirus disease 2019 (COVID-19) situation report—199[R]. WHO, 2020.
|
5 |
Mathuria JP, Yadav R, Rajkumar. Laboratory diagnosis of SARS-CoV-2-A review of current methods[J]. J Infect Public Health, 2020, 13: 901-905.
|
6 |
国家卫生健康委办公厅, 国家中医药管理局办公室. 国家卫生健康委办公厅关于印发新型冠状病毒肺炎防控方案(试运行第七版)的通知[EB/OL]. (2020-03-03)
URL
|
7 |
张瑞, 李金明. 2019新型冠状病毒特异抗体检测"假阳性"原因分析及对策[J] 中华检验医学杂志, 2020, 43(5):507-510.
|
8 |
Liya G, Yuguang W, Jian L, et al. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review[J]. APMIS, 2020, 128: 423-432.
|
9 |
Moreno-Eutimio MA, Lopez-Macias C, Pastelin-Palacios R. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes[J]. Microbes Infect, 2020, 22(4-5):226-229.
|
10 |
Shang J, Wan Y, Luo C, et al. Cell entry mechanisms of SARS-CoV-2[J]. Proc Natl Acad Sci, 2020, 117(21):11727-11734.
|
11 |
Lei C, Qian K, Li T, et al. Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig[J]. Nat. Commun, 2020, 11(1): 1-5.
|
12 |
张典, 牛慧, 王晓晓, 等. 冠状病毒的病原学特征与宿主免疫功能调控的研究进展[J]. 临床肺科杂志, 2020, 25(7):1100-1104.
|
13 |
Zhang F, Gan R, Zhen Z, et al. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals[J]. Signal Transduct Tar, 2020, 5(1): 1-11.
|
14 |
Li Z, Yi Y, Luo X, et al. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis[J]. J Med Virl, 2020, 92(9):1518-1524.
|
15 |
Xu X, Sun J, Nie S, et al. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China[J]. Nat Med, 2020, 26(8):1193-1195.
|
16 |
徐万洲, 李娟, 何晓云, 等. 血清2019新型冠状病毒IgM和IgG抗体联合检测在新型冠状病毒感染中的诊断价值[J]. 中华检验医学杂志, 2020, 43(3):230-233.
|
17 |
Iversen K, Bundgaard H, Hasselbalch R B, et al. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study[J]. The Lancet Infectious Diseases, 2020, 20(12):1401-1408.
|
18 |
Sotgiu G, Barassi A, Miozzo M, et al. SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital[J]. BMC Pulm Med, 2020, 20: 203.
|
19 |
Bhaskar M E, Arun S. SARS-CoV-2 infection among community health workers in india before and after use of face shields[J]. Jama, 2020, 324(13): 1348-1349.
|
20 |
Zhu S, Zong Z. Why did so few healthcare workers in China get COVID-19 infection[J]. QJM: An International Journal of Medicine, 2020, 1-2.
|
21 |
Kaur S P, Gupta V. COVID-19 Vaccine: A comprehensive status report[J] Virus Research, 2020, 288:198114.
|